Insider Title Company Date Price Return Shares Value
Vaddi Krishna CEO Prelude Therapeutics Inc (PRLD) 2024-12-19 $0.93 0.0% 106,888 $99,326
Vaddi Krishna CEO Prelude Therapeutics Inc (PRLD) 2023-05-25 $5.15 -6.7% 1,900 $9,790
Vaddi Krishna CEO Prelude Therapeutics Inc (PRLD) 2023-05-23 $5.63 -14.6% 11,856 $66,749
Vaddi Krishna CEO Prelude Therapeutics Inc (PRLD) 2022-12-20 $5.13 -6.2% 19,188 $98,446
Return Profit / (loss) Cost
Total -6.0% $-16,525 $274,311